Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
Manisha Pandey(Griffith University), Michael F. Good(Griffith University), István Tóth(The University of Queensland), Ailin Lepletier(Griffith University), James T. Williams(Gold Coast Hospital), Ainslie Calcutt(Griffith University), Mariusz Skwarczyński(The University of Queensland), Holly A. Saffran(University of Alberta), Christopher J. Day(Griffith University), Jamie‐Lee Mills(TAFE Queensland Gold Coast), Danielle I. Stanisic(Griffith University), Victoria Ozberk(Griffith University), D. Lorne Tyrrell(University of Alberta), Johnson Mak(Griffith University), John Gerrard(Gold Coast Hospital), Sharareh Eskandari(University of Queensland), Laetitia Hattingh(Curtin University), Ahmed O. Shalash(The University of Queensland), Fan Fan(Fudan University), Michael Joyce(University of Alberta), Belinda L. Spillings(Griffith University), Michael P. Jennings(Griffith University)
Cited by 21
Related Papers
Peptide-based synthetic vaccines
|Chemical Science|2015|592
Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering
|Advanced Drug Delivery Reviews|2016|370
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation
|Nature Communications|2018|190